1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow nirsevimab: new trials by email Literature Review of nirsevimab trials Research Report on nirsevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV) | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 36 | 2026-01-15 | 2026-01-23 |
| Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children Nirsevimab - RSV Infection | Phase 2 | Completed | AstraZeneca | 100 | 2020-08-19 | 2023-11-15 |
Premature Birth (1) · Respiratory Syncytial Virus Infections (1)
AstraZeneca (1) · Shanghai Institute Of Biological Products (1)
Belgium (1) · China (1) · Japan (1) · Poland (1) · South Africa (1) · Spain (1) · Ukraine (1) · United Kingdom (1) · United States (1)
Hanwen Liu (1)